JORDAN COHO: Open Payments
NPI 1073286423 · ALTOONA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$511 in 29 payments from 10 companies in 2025. Trend: 2023 $375 · 2024 $423 · 2025 $511
Food & beverage: $511
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $145 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $104 |
| Novo Nordisk Inc | 4 | $79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $47 |
| AKEBIA THERAPEUTICS INC | 2 | $37 |
| Mallinckrodt Hospital Products Inc. | 1 | $24 |
| SCPHARMACEUTICALS INC. | 1 | $23 |
| Apellis Pharmaceuticals, Inc. | 1 | $21 |
| Calliditas Therapeutics US Inc. | 1 | $16 |
| Travere Therapeutics, Inc. | 1 | $14 |
Products named: JYNARQUE, Kerendia, Wegovy, JARDIANCE, Vafseo, TERLIVAZ, FUROSCIX, VOYXACT.
Industry payments across PA — which companies pay providers there.
